Company | Market cap | P/E | Price | Change | % Change | YTD change |
|---|---|---|---|---|---|---|
| ACAD ACADIA Pharmaceuticals, Inc. | $1.1B | NM | 14.19 | +0.399 | +2.89% | +205.14% |
| AXDX Accelerate Diagnostics, Inc. | $336.8M | NM | 8.67 | +0.07 | +0.81% | +115.14% |
| ACHN Achillion Pharmaceuticals, Inc. | $731.9M | NM | 7.58 | -0.06 | -0.79% | -5.37% |
| ACOR Acorda Therapeutics, Inc. | $1.3B | 9.0 | 32.67 | +0.44 | +1.37% | +31.42% |
| ACTC Advanced Cell Technology, Inc. | $178.0M | NM | 0.073 | +0.0005 | +0.69% | +31.06% |
| ADXS Advaxis, Inc. | $22.7M | NM | 0.041 | -0.002 | -4.65% | +36.67% |
| AEGR Aegerion Pharmaceuticals, Inc. | $1.7B | NM | 60.09 | -0.87 | -1.43% | +136.76% |
| AEZS AEterna Zentaris, Inc. | $51.2M | -- | 2.02 | -0.01 | -0.49% | -15.13% |
| AFFY Affymax, Inc. | $52.1M | NM | 1.39 | -0.01 | -0.71% | -92.68% |
| AFFX Affymetrix, Inc. | $260.9M | NM | 3.67 | -0.01 | -0.27% | +15.77% |
| AGEN Agenus, Inc. | $115.2M | NM | 4.07 | -0.05 | -1.21% | -0.73% |
| ALXN Alexion Pharmaceuticals, Inc. | $19.4B | 68.4 | 99.17 | -0.71 | -0.71% | +5.79% |
| ALIM Alimera Sciences, Inc. | $140.2M | NM | 4.44 | +0.01 | +0.23% | +182.80% |
| ALKS Alkermes Plc | $4.3B | NM | 32.84 | -0.16 | -0.48% | +77.32% |
| ALNY Alnylam Pharmaceuticals, Inc. | $1.8B | NM | 28.98 | +0.92 | +3.28% | +58.79% |
| AMAG AMAG Pharmaceuticals, Inc. | $480.0M | NM | 22.25 | +0.31 | +1.41% | +51.26% |
| AMGN Amgen, Inc. | $79.4B | 17.9 | 105.91 | +0.29 | +0.27% | +22.87% |
| FOLD Amicus Therapeutics, Inc. | $168.7M | NM | 3.40 | -0.02 | -0.58% | +26.87% |
| ANAC Anacor Pharmaceuticals, Inc. | $222.7M | NM | 5.50 | +0.03 | +0.55% | +5.77% |
| ANDF Andain, Inc. | $2.8M | -- | 0.049 | -0.001 | -2.00% | -18.33% |
.
